Last reviewed · How we verify
Chronic Heart Failure Following Myocardial Infarction
Approved treatments
- Inspra · Upjohn
Inspra works by blocking the action of aldosterone, a hormone that can cause the body to retain too much salt and water.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Chronic Heart Failure Following Myocardial Infarction patent landscape — cliff calendar, originator estates, attackable patents
- Chronic Heart Failure Following Myocardial Infarction treatment landscape brief
- Chronic Heart Failure Following Myocardial Infarction treatment updates RSS
Frequently asked questions about Chronic Heart Failure Following Myocardial Infarction
What drugs treat Chronic Heart Failure Following Myocardial Infarction?
Tracked treatments include Inspra.
What is the treatment for Chronic Heart Failure Following Myocardial Infarction?
Standard treatment for Chronic Heart Failure Following Myocardial Infarction includes Inspra. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Chronic Heart Failure Following Myocardial Infarction patent cliff · Chronic Heart Failure Following Myocardial Infarction CI report
- Treatment: Inspra · Upjohn
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing